UCL Translational Research Office

The TRO operates a unique approach with an academic-led focus on the patient, providing advice and tailored support to build a strong translational strategy.

UCL TRO’s skills and expertise includes:

• Industry trained applied scientists/project leaders
• Drug discovery medicinal chemists, assay biologists
• Therapeutic translational advisors
• Grant, portfolio, project and alliance managers
• Healthcare management consultants
• Business developers

For more information, visit the UCL TRO website here. To view the TRO’s 10 year report for details of the groups funding successes and case studies, visit here.

In addition, the UCL Therapeutic Innovation Networks (TINs) were initiated by the TRO in 2015, as ‘community of practices’ around six therapeutic modalities - Biologics, Cell & Gene Therapy, Devices & Diagnostics, Regenerative Medicine, Repurposing and Small Molecules.

The aim of the networks is to encourage multidisciplinary shared learning across the university, partner hospitals, and with industry partners, to address common healthcare challenges. Through creating a ‘critical mass’ of academic investigators and allowing the opportunity to showcase UCL’s strengths and capabilities across key therapeutic modalities and translational processes, the TINs further facilitate strategic collaboration with external partners.

Visit here to join the Therapeutic Innovation Networks (TINs).